Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMC 3772068)

Published in PLoS Comput Biol on September 12, 2013

Authors

John C Williams1, Jianjin Xu, Zhongju Lu, Aleksandra Klimas, Xuxin Chen, Christina M Ambrosi, Ira S Cohen, Emilia Entcheva

Author Affiliations

1: Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York, United States of America.

Articles citing this

All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins. Nat Methods (2014) 2.41

"Beauty is a light in the heart": the transformative potential of optogenetics for clinical applications in cardiovascular medicine. Trends Cardiovasc Med (2014) 1.47

Optical mapping of optogenetically shaped cardiac action potentials. Sci Rep (2014) 1.16

Cardiac applications of optogenetics. Prog Biophys Mol Biol (2014) 0.95

Distinct roles for GABA across multiple timescales in mammalian circadian timekeeping. Proc Natl Acad Sci U S A (2015) 0.93

Optogenetics' promise: pacing and cardioversion by light? Future Cardiol (2014) 0.91

Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach. Europace (2014) 0.88

Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study. J Physiol (2016) 0.87

Toward microendoscopy-inspired cardiac optogenetics in vivo: technical overview and perspective. J Biomed Opt (2014) 0.86

OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology. Nat Commun (2016) 0.85

See the light: can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort? Expert Rev Cardiovasc Ther (2013) 0.84

Channelrhodopsin2 current during the action potential: "optical AP clamp" and approximation. Sci Rep (2014) 0.84

Cardiac Optogenetics: Enhancement by All-trans-Retinal. Sci Rep (2015) 0.82

Optogenetics-enabled assessment of viral gene and cell therapy for restoration of cardiac excitability. Sci Rep (2015) 0.81

All-optical control of cardiac excitation: combined high-resolution optogenetic actuation and optical mapping. J Physiol (2016) 0.80

Optogenetic versus Electrical Stimulation of Human Cardiomyocytes: Modeling Insights. Biophys J (2015) 0.80

Computational modeling of cardiac optogenetics: Methodology overview & review of findings from simulations. Comput Biol Med (2015) 0.79

Brief wide-field photostimuli evoke and modulate oscillatory reverberating activity in cortical networks. Sci Rep (2016) 0.78

Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations. J Clin Invest (2016) 0.77

PyRhO: A Multiscale Optogenetics Simulation Platform. Front Neuroinform (2016) 0.75

Acute Optogenetic Modulation of Cardiac Twitch Dynamics Explored Through Modeling. J Biomech Eng (2016) 0.75

Light-based Approaches to Cardiac Arrhythmia Research: From Basic Science to Translational Applications. Clin Med Insights Cardiol (2016) 0.75

Fiat lux in understanding cardiac pacing, resynchronization and signalling by way of optogenetics. Cardiovasc Res (2014) 0.75

Adjacent channelrhodopsin-2 residues within transmembranes 2 and 7 regulate cation selectivity and distribution of the two open states. J Biol Chem (2017) 0.75

Inscribing Optical Excitability to Non-Excitable Cardiac Cells: Viral Delivery of Optogenetic Tools in Primary Cardiac Fibroblasts. Methods Mol Biol (2016) 0.75

A high-conductance chemo-optogenetic system based on the vertebrate channel Trpa1b. Sci Rep (2017) 0.75

Articles cited by this

A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (1952) 160.83

Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci (2005) 28.08

Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A (2003) 15.17

Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses. Curr Biol (2005) 8.01

Optogenetics in neural systems. Neuron (2011) 7.56

Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature (1994) 6.45

Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev (2004) 5.79

Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+. Nature (1987) 5.44

Spermine and spermidine as gating molecules for inward rectifier K+ channels. Science (1994) 4.82

Characterization of engineered channelrhodopsin variants with improved properties and kinetics. Biophys J (2009) 4.75

Ultrafast optogenetic control. Nat Neurosci (2010) 4.73

Bi-stable neural state switches. Nat Neurosci (2008) 4.69

Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins. Nat Methods (2011) 4.27

Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci (2006) 3.95

Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol (1998) 3.41

Alternans and spiral breakup in a human ventricular tissue model. Am J Physiol Heart Circ Physiol (2006) 3.36

Spectral characteristics of the photocycle of channelrhodopsin-2 and its implication for channel function. J Mol Biol (2007) 2.88

Crystal structure of the channelrhodopsin light-gated cation channel. Nature (2012) 2.83

Modeling the heart--from genes to cells to the whole organ. Science (2002) 2.76

High-efficiency channelrhodopsins for fast neuronal stimulation at low light levels. Proc Natl Acad Sci U S A (2011) 2.67

Global structure, robustness, and modulation of neuronal models. J Neurosci (2001) 2.62

Optogenetic control of heart muscle in vitro and in vivo. Nat Methods (2010) 2.47

Multiple photocycles of channelrhodopsin. Biophys J (2005) 2.40

Photoactivation of channelrhodopsin. J Biol Chem (2007) 2.26

Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol (2011) 2.18

Channelrhodopsin-2 is a leaky proton pump. Proc Natl Acad Sci U S A (2009) 1.87

Photocycles of channelrhodopsin-2. Photochem Photobiol (2009) 1.76

Intracellular polyamines mediate inward rectification of Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proc Natl Acad Sci U S A (1995) 1.70

Cell surface heating during fluorescence photobleaching recovery experiments. Biophys J (1977) 1.67

Rectification of muscarinic K+ current by magnesium ion in guinea pig atrial cells. Am J Physiol (1987) 1.61

Optogenetics and thermogenetics: technologies for controlling the activity of targeted cells within intact neural circuits. Curr Opin Neurobiol (2011) 1.55

Regulation of Ca2+ and electrical alternans in cardiac myocytes: role of CAMKII and repolarizing currents. Am J Physiol Heart Circ Physiol (2007) 1.45

Ionic currents contributing to the action potential in single ventricular myocytes of the guinea pig studied with action potential clamp. Pflugers Arch (1990) 1.42

Multiscale computational models for optogenetic control of cardiac function. Biophys J (2011) 1.34

Isoprenaline, Ca2+ and the Na(+)-K+ pump in guinea-pig ventricular myocytes. J Physiol (1992) 1.30

The mechanism of rectification of iK1 in canine Purkinje myocytes. J Gen Physiol (1990) 1.28

Projection structure of channelrhodopsin-2 at 6 Å resolution by electron crystallography. J Mol Biol (2011) 1.24

Cardiac optogenetics. Am J Physiol Heart Circ Physiol (2013) 1.24

Effects on capacitance by overexpression of membrane proteins. Biochem Biophys Res Commun (2008) 1.22

Evolution of the channelrhodopsin photocycle model. Chemphyschem (2010) 1.17

A computational model of Purkinje fibre single cell electrophysiology: implications for the long QT syndrome. J Physiol (2010) 1.15

Rectification of the channelrhodopsin early conductance. Biophys J (2011) 1.11

Theoretical principles underlying optical stimulation of a channelrhodopsin-2 positive pyramidal neuron. J Neurophysiol (2012) 1.09

Modeling study of the light stimulation of a neuron cell with channelrhodopsin-2 mutants. IEEE Trans Biomed Eng (2011) 1.09

Optogenetics and psychiatry: applications, challenges, and opportunities. Biol Psychiatry (2012) 1.06

Voltage- and temperature-dependent gating of heterologously expressed channelrhodopsin-2. J Neurosci Methods (2010) 0.96

Rectification of rabbit cardiac ryanodine receptor current by endogenous polyamines. Biophys J (1996) 0.96

Computational Optogenetics: A Novel Continuum Framework for the Photoelectrochemistry of Living Systems. J Mech Phys Solids (2012) 0.92

Control of neural synchrony using channelrhodopsin-2: a computational study. J Comput Neurosci (2010) 0.85

Effects of temperature on human L-type cardiac Ca2+ channels expressed in Xenopus oocytes. Pflugers Arch (1998) 0.83

Sensitivity of cloned muscle, heart and neuronal voltage-gated sodium channels to block by polyamines: a possible basis for modulation of excitability in vivo. Channels (Austin) (2012) 0.79

Articles by these authors

Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23

Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol (2011) 2.18

Suppression of phosphoinositide 3-kinase signaling and alteration of multiple ion currents in drug-induced long QT syndrome. Sci Transl Med (2012) 1.99

Structural and functional evidence for discrete exit pathways that connect the canine sinoatrial node and atria. Circ Res (2009) 1.90

Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells (2007) 1.85

Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells (2007) 1.84

Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res (2004) 1.79

Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials (2005) 1.79

Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation (2007) 1.76

Expression and function of a biological pacemaker in canine heart. Circulation (2003) 1.67

Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol (2004) 1.65

Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemaker. Circulation (2006) 1.61

Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation (2004) 1.61

Cardiac expression of skeletal muscle sodium channels increases longitudinal conduction velocity in the canine 1-week myocardial infarction. Heart Rhythm (2010) 1.57

Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem (2008) 1.56

HCN2/SkM1 gene transfer into canine left bundle branch induces stable, autonomically responsive biological pacing at physiological heart rates. J Am Coll Cardiol (2013) 1.56

Expression of skeletal muscle sodium channel (Nav1.4) or connexin32 prevents reperfusion arrhythmias in murine heart. Cardiovasc Res (2010) 1.49

Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation (2005) 1.43

The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant (2006) 1.42

Genes, stem cells and biological pacemakers. Cardiovasc Res (2004) 1.40

Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol (2011) 1.34

Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study. Circulation (2008) 1.32

MiRP1 modulates HCN2 channel expression and gating in cardiac myocytes. J Biol Chem (2004) 1.31

A comprehensive multiscale framework for simulating optogenetics in the heart. Nat Commun (2013) 1.27

The road to biological pacing. Nat Rev Cardiol (2011) 1.27

The role of cardiac tissue alignment in modulating electrical function. J Cardiovasc Electrophysiol (2007) 1.23

Calcium instabilities in mammalian cardiomyocyte networks. Biophys J (2006) 1.22

Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction. Circulation (2009) 1.22

Angiotensin receptor type 1 forms a complex with the transient outward potassium channel Kv4.3 and regulates its gating properties and intracellular localization. J Biol Chem (2004) 1.15

Calcium channel heterogeneity in canine left ventricular myocytes. J Physiol (2003) 1.14

Scaffold topography alters intracellular calcium dynamics in cultured cardiomyocyte networks. Am J Physiol Heart Circ Physiol (2004) 1.12

Role of L-type calcium channels in pacing-induced short-term and long-term cardiac memory in canine heart. Circulation (2003) 1.12

HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade. Heart Rhythm (2007) 1.11

Tyrosine kinase inhibition differentially regulates heterologously expressed HCN channels. Pflugers Arch (2003) 1.11

Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage. Am J Physiol Heart Circ Physiol (2008) 1.10

Cardiac pacing: from biological to electronic ... to biological? Circ Arrhythm Electrophysiol (2008) 1.08

Cardiac memory ... new insights into molecular mechanisms. J Physiol (2005) 1.08

Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization. FASEB J (2010) 1.08

Biological pacemakers in canines exhibit positive chronotropic response to emotional arousal. Heart Rhythm (2010) 1.07

Cardiac cell networks on elastic microgrooved scaffolds. IEEE Eng Med Biol Mag (2003) 1.07

A transgenic mouse model of heart failure using inducible Galpha q. J Biol Chem (2005) 1.07

Biological pacemakers based on I(f). Med Biol Eng Comput (2006) 1.07

Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides. J Gen Physiol (2002) 1.06

Decreased L-type Ca2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling. Diabetes (2007) 1.05

Constitutively active Src tyrosine kinase changes gating of HCN4 channels through direct binding to the channel proteins. J Cardiovasc Pharmacol (2006) 1.05

Can gap junctions deliver? Biochim Biophys Acta (2011) 1.04

PI3Ks maintain the structural integrity of T-tubules in cardiac myocytes. PLoS One (2011) 1.03

I(f) and the biological pacemaker. Pharmacol Res (2006) 1.01

Increased myocyte content and mechanical function within a tissue-engineered myocardial patch following implantation. Tissue Eng Part A (2009) 1.00

Galpha q inhibits cardiac L-type Ca2+ channels through phosphatidylinositol 3-kinase. J Biol Chem (2005) 0.99

Ca(2+)-stimulated adenylyl cyclase AC1 generates efficient biological pacing as single gene therapy and in combination with HCN2. Circulation (2012) 0.99

Optogenetic control of cardiomyocytes via viral delivery. Methods Mol Biol (2014) 0.97

Comparison of the effects of cyclic stretching and compression on endothelial cell morphological responses. J Biomech Eng (2004) 0.92

PI3K and ERK/Nrf2 pathways are involved in oleanolic acid-induced heme oxygenase-1 expression in rat vascular smooth muscle cells. J Cell Biochem (2011) 0.92

Repairing damaged myocardium: evaluating cells used for cardiac regeneration. Curr Treat Options Cardiovasc Med (2008) 0.92

Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart. Diabetes (2013) 0.91

Optogenetics' promise: pacing and cardioversion by light? Future Cardiol (2014) 0.91

Anatomic localization and autonomic modulation of atrioventricular junctional rhythm in failing human hearts. Circ Arrhythm Electrophysiol (2011) 0.90

Regenerative therapies in electrophysiology and pacing. J Interv Card Electrophysiol (2008) 0.89

Cardiac cellular coupling and the spread of early instabilities in intracellular Ca2+. Biophys J (2012) 0.89

Expression of skeletal but not cardiac Na+ channel isoform preserves normal conduction in a depolarized cardiac syncytium. Cardiovasc Res (2008) 0.89

A transmural gradient in the cardiac Na/K pump generates a transmural gradient in Na/Ca exchange. J Membr Biol (2010) 0.88

Cardiac regeneration: materials can improve the passive properties of myocardium, but cell therapy must do more. Circulation (2006) 0.88

Right ventricular arrhythmogenesis in failing human heart: the role of conduction and repolarization remodeling. Am J Physiol Heart Circ Physiol (2012) 0.88

Intracellular ATP binding is required to activate the slowly activating K+ channel I(Ks). Proc Natl Acad Sci U S A (2013) 0.88

Bitter tastants induce relaxation of rat thoracic aorta precontracted with high K(+). Clin Exp Pharmacol Physiol (2014) 0.87

Apoptotic endothelial cells demonstrate increased adhesiveness for human mesenchymal stem cells. J Cell Physiol (2009) 0.86

Microtubules and angiotensin II receptors contribute to modulation of repolarization induced by ventricular pacing. Heart Rhythm (2012) 0.86

Lenses and effective spatial resolution in macroscopic optical mapping. Phys Med Biol (2007) 0.86

Implantation of sinoatrial node cells into canine right ventricle: biological pacing appears limited by the substrate. Cell Transplant (2011) 0.86

See the light: can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort? Expert Rev Cardiovasc Ther (2013) 0.84

Restoration of defective L-type Ca2+ current in cardiac myocytes of type 2 diabetic db/db mice by Akt and PKC-ι. J Cardiovasc Pharmacol (2011) 0.84

Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature. Echocardiography (2009) 0.83

A Caveat Emptor for myocardial regeneration: mechanical without electrical recovery will not suffice. J Mol Cell Cardiol (2006) 0.82

Von willebrand factor increases endothelial cell adhesiveness for human mesenchymal stem cells by activating p38 mitogen-activated protein kinase. Stem Cell Res Ther (2010) 0.82

Voltage-gated ion channel Kv4.3 is associated with Rap guanine nucleotide exchange factors and regulates angiotensin receptor type 1 signaling to small G-protein Rap. FEBS J (2007) 0.82

Recreating the biological pacemaker. Anat Rec A Discov Mol Cell Evol Biol (2004) 0.82

The effects of the histone deacetylase inhibitor 4-phenylbutyrate on gap junction conductance and permeability. Front Pharmacol (2013) 0.82

Simultaneous assessment of myocardial perfusion and function during mental stress in patients with chronic coronary artery disease. J Nucl Cardiol (2003) 0.82

Reversible heart failure in G alpha(q) transgenic mice. J Biol Chem (2006) 0.81

Detecting space-time alternating biological signals close to the bifurcation point. IEEE Trans Biomed Eng (2009) 0.81

CellExcite: an efficient simulation environment for excitable cells. BMC Bioinformatics (2008) 0.79

Both metabolic inhibition and mitochondrial K(ATP) channel opening are myoprotective and initiate a compensatory sarcolemmal outward membrane current. Circulation (2003) 0.79

A sensitive algorithm for automatic detection of space-time alternating signals in cardiac tissue. Conf Proc IEEE Eng Med Biol Soc (2008) 0.78